Table 1. Prediagnostic Changes in Viral... | American Society of Hematology

Table 1.

Prediagnostic Changes in Viral Markers, Ably, and Leukocyte Count Among the Six ATL Cases in the Miyazaki Cohort Study

Case No.	No. of Controls	Sex	Date of Diagnosis	Date of Death	Age at Death	Smoking	Anti–HTLV-I Titer	Anti-Tax Reactivity	Ably Level in %	Leukocyte Count	Screen Year
1^*	—	M	05/1982	08/1987	66	Yes	8,192	−	0.0	7,400	1986
2	10	F	NA	02/1987	69	No	512	±	0.2	4,300	1985
3	11	M	NA	08/1990	64	Yes	8,192	−	1.1	6,400	1985
							8,192	−	NA	9,600	1987
4	3	M	08/1991	04/1992	78	Yes	8,192	−	0.6	4,300	1984
							8,192	−	0.6	5,100	1985
5	5	M	10/1994	12/1994	83	Yes	1,024	+	0.2	4,800	1985
							2,048	+	0.6	4,800	1989
6	9	F	07/1994	05/1995	77	No	512	±	0.4	5,800	1985
							256	±	0.6	4,300	1989
							512	±	NA	3,800	1992

Case No.	No. of Controls	Sex	Date of Diagnosis	Date of Death	Age at Death	Smoking	Anti–HTLV-I Titer	Anti-Tax Reactivity	Ably Level in %	Leukocyte Count	Screen Year
1^*	—	M	05/1982	08/1987	66	Yes	8,192	−	0.0	7,400	1986
2	10	F	NA	02/1987	69	No	512	±	0.2	4,300	1985
3	11	M	NA	08/1990	64	Yes	8,192	−	1.1	6,400	1985
							8,192	−	NA	9,600	1987
4	3	M	08/1991	04/1992	78	Yes	8,192	−	0.6	4,300	1984
							8,192	−	0.6	5,100	1985
5	5	M	10/1994	12/1994	83	Yes	1,024	+	0.2	4,800	1985
							2,048	+	0.6	4,800	1989
6	9	F	07/1994	05/1995	77	No	512	±	0.4	5,800	1985
							256	±	0.6	4,300	1989
							512	±	NA	3,800	1992

Abbreviation: NA, not available.

Measurements of all markers for this prevalent case were posttreatment. This case is not included in the case-control analysis.